<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">Indian Journal of Ophthalmology</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0301-4738</issn>
      <issn pub-type="epub">1998-3689</issn>
      <publisher>
        <publisher-name>Medknow Publications</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17699951</article-id>
      <article-id pub-id-type="pmc">2636015</article-id>
      <article-id pub-id-type="publisher-id">IndianJOphthalmol_2007_55_5_380_33828</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Clinicopathologic correlations in eyes enucleated after uveal melanoma resection with positive surgical margins</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Khalifa</surname>
            <given-names>Yousuf</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aaberg Jr</surname>
            <given-names>Thomas M</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aaberg Sr</surname>
            <given-names>Thomas M</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Grossniklaus</surname>
            <given-names>Hans E</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <aff>
Departments of Ophthalmology (YK, TMA, TMA, HEG) and Pathology (HEG), Emory University School of Medicine, Atlanta, Georgia, USA</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Correspondence to Dr. Hans E. Grossniklaus, L.F. Montgomery Laboratory, BT428 Emory Eye Center, 1365 Clift on Road NE, Atlanta, GA 30307, USA. Email: <email>ophtheg@emory.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2007</year>
      </pub-date>
      <volume>55</volume>
      <issue>5</issue>
      <fpage>380</fpage>
      <lpage>383</lpage>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>6</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>10</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Ophthalmology</copyright-statement>
        <copyright-year>2007</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an 
open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly 
cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We identified three eyes that had undergone enucleation after transscleral resection of uveal melanoma. Two enucleated eyes with microscopically positive margins of resection exhibited no evidence of residual melanoma and these patients were alive without metastasis with at least four years&#x2032; follow-up. One eye with a transected melanoma contained residual melanoma and that patient died with metastatic melanoma to the liver three years after enucleation. There appear to be at least two general types of positive surgical margins of resection of uveal melanoma: microscopically positive margins and macroscopically positive (transected) margins of resection.</p>
      </abstract>
      <kwd-group>
        <kwd>Resection</kwd>
        <kwd>surgical margins</kwd>
        <kwd>uveal melanoma
</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Currently, there is no evidence that indicates the superiority of any single treatment modality with regard to survival of the patient with uveal melanoma.<xref ref-type="bibr" rid="ref1">1</xref>  Local resection may be appropriate for certain ciliary body melanomas or ciliochoroidal melanomas.<xref ref-type="bibr" rid="ref2">2</xref>  Local resection of uveal melanoma is a technically demanding procedure with a high incidence of positive or questionable surgical margins of resection.<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>  The purpose of this study was to understand the implications of positive surgical margins of resection.</p>
    <sec sec-type="">
      <title>Case Reports</title>
      <sec>
        <title>Case 1</title>
        <p>A 79-year-old man who had a history of age-related macular degeneration was found on routine ophthalmic examination to have a minimally pigmented tumor in the ciliary body and choroid of his right eye. The patient underwent a lensectomy, cyclectomy and eye wall resection for the tumor. The resected specimen showed a 10 mm diameter X 8 mm thickness minimally pigmented ciliary body/choroidal tumor <xref ref-type="fig" rid="F1">[Fig. 1]</xref>. Microscopic examination showed a mixed cell type melanoma that extended to the lateral margins of resection, although the tumor was not transected <xref ref-type="fig" rid="F2">[Fig. 2]</xref>. The patient developed proliferative vitreoretinopathy, a tractional retinal detachment, fibrovascular ingrowth and a blind, painful right eye. He underwent enucleation nine months after local resection. The enucleated eye showed no residual melanoma <xref ref-type="fig" rid="F3">[Fig. 3]</xref>. There was redundant, gliotic retina and proliferated ciliary body epithelium posterior to the resected ciliary body <xref ref-type="fig" rid="F4">[Fig. 4]</xref>. There was no residual melanoma. The patient had no evidence of metastatic melanoma four years after enucleation.</p>
      </sec>
      <sec>
        <title>
Case 2</title>
        <p>A 45-year-old man with a two-week history of cloudy vision was found to have a moderately pigmented tumor of the ciliary body and peripheral iris in his right eye. The patient underwent an iridocyclectomy and partial eye wall resection. The resected specimen showed a moderately pigmented 9 mm diameter X 4 mm thickness tumor. Microscopic examination showed an epithelioid cell type melanoma that extended to the posterior and lateral margins of resection, although the tumor was not transected. The patient developed a vitreous hemorrhage and due to microscopic extension of the melanoma, the eye was enucleated two weeks later. Examination of the enucleated specimen showed the site of iridocyclectomy temporally and no evidence of residual melanoma. The patient had no evidence of metastasis five years after enucleation.</p>
      </sec>
      <sec>
        <title>
Case 3</title>
        <p>A 56-year-old man was found to have a moderately pigmented ciliary body/choroidal tumor in his right eye during a routine ophthalmic examination. A lamellar sclerouveactomy was performed. The resection specimen showed a 12 mm diameter X 5 mm thickness multilobed tumor <xref ref-type="fig" rid="F5">[Fig. 5]</xref>. Microscopic examination showed a mixed cell type melanoma with the posterior margin of the tumor transected <xref ref-type="fig" rid="F6">[Fig. 6]</xref>. Due to transection of the melanoma, the eye was enucleated two weeks later. The enucleation specimen showed the site of previous sclerouveactomy temporally with a 3X3mm nodule of residual melanoma <xref ref-type="fig" rid="F7">[Fig. 7]</xref>. Microscopic examination confirmed the residual melanoma <xref ref-type="fig" rid="F8">[Fig. 8]</xref>. An abdominal CT three years after enucleation showed multiple liver nodules, consistent with metastatic melanoma. The patient died three years after enucleation.</p>
      </sec>
    </sec>
    <sec sec-type="">
      <title>Discussion</title>
      <p>In a matched, case-control study comparing transscleral resection and I<sup> 125</sup>  brachytherapy for uveal melanoma, patients who underwent transcleral resection were found to have a significantly smaller risk of developing cataract, vitreous hemorrhage and maculopathy compared to those treated with brachytherapy.<xref ref-type="bibr" rid="ref8">8</xref>  Additionally, rubeosis, glaucoma and optic neuropathy were found only in the brachytherapy group.<xref ref-type="bibr" rid="ref8">8</xref>  Melanoma-specific survival after I<sup> 125</sup>  and local resection were comparable. There was greater local tumor control in the I<sup> 125</sup>  treated group compared with the locally resected group.<xref ref-type="bibr" rid="ref8">8</xref> </p>
      <p>Local resection of uveal melanoma is technically demanding with numerous associated risks including vitreous hemorrhage, retinal/subretinal hemorrhage, ptosis, cataract, retinal detachment, proliferative vitreoretinopathy (PVR), choroidal detachment and persistent corneal edema.<xref ref-type="bibr" rid="ref9">9</xref>  Two series have reported positive or questionably positive margins of excision in 68 of 138 patients (49.3%)<xref ref-type="bibr" rid="ref4">4</xref>  and 174 of 286 (60.8%)<xref ref-type="bibr" rid="ref5">5</xref>  patients. However, recurrent melanoma was found in only 13 of 138 patients (9.4%)<xref ref-type="bibr" rid="ref4">4</xref>  and 57 of 286 patients (19.9%)<xref ref-type="bibr" rid="ref5">5</xref>  in those series. Other studies have reported similar incidences of recurrence after local resection ranging from 3 to 18%.<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>  Our laboratory has evaluated 5/12 (41%) resected melanomas with positive surgical margins of resection and 1/12 (8%) that recurred, similar to the published series.<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>  Although recurrences were probably prevented by additional treatment with brachytherapy in some of those cases, it is clear that positive surgical margins of resection without additional treatment did not lead to persistent (recurrent) tumor in many cases.<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>  None of the patients in this report had additional treatment for their uveal melanoma.</p>
      <p>The relatively high rates of positive surgical margins after local resection of uveal melanoma may be explained by the fact that the uveal tract is a continuous tissue without anatomic barriers that prevent lateral spread of melanoma. Noncontiguous tumor recurrence of uveal melanoma after local resection has been reported.<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref10">10</xref>  Evaluation of the surgical margins of resection is, at best, a percentage of the margin of the entire specimen. An inadequately sampled margin, multifocal tumor or a separate primary melanoma may account for tumor persistence (recurrence) after reportedly negative margins. However, melanoma recurs in only approximately 20 to 33% of eyes after local resection with positive surgical margins.<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>  This may be due to secondary treatment (i.e. brachytherapy), spontaneous regression of residual melanoma or melanoma extending to but not beyond the surgical margin. Our cases provide examples of two general types of positive surgical margin of excision of uveal melanoma. The first type is the microscopically positive margin, as seen in Cases 1 and 2. The second type of positive margin occurs when the tumor is transected.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Donoso</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Management of posterior uveal melanoma</article-title>
          <source>Surv Ophthalmol</source>
          <year>1991</year>
          <volume>36</volume>
          <fpage>161</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">1776122</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Chapt 11. Management of Posterior Uveal Melanoma</article-title>
          <source>Intraocular Tumors: A Text and Atlas</source>
          <year>1992</year>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>WB Saunders</publisher-name>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sivalingam</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Partial lamellar sclerouvectomy of ciliary body and choroidal tumors</article-title>
          <source>Ophthalmology</source>
          <year>1991</year>
          <volume>98</volume>
          <fpage>971</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">1866153</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Char</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Uveal tumor resections</article-title>
          <source>Br J Ophthalmol</source>
          <year>2001</year>
          <volume>85</volume>
          <fpage>1213</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">11567967</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Damato</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Foulds</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection</article-title>
          <source>Br J Ophthalmol</source>
          <year>1996</year>
          <volume>80</volume>
          <fpage>102</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">8814738</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foulds</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>Current options in the management of choroidal melanoma</article-title>
          <source>Trans Ophthalmol Soc UK</source>
          <year>1983</year>
          <volume>103</volume>
          <fpage>28</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">6362109</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Damato</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Foulds</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>Predictive factors for visual outcome after local resection of choroidal melanoma</article-title>
          <source>Br J Ophthalmol</source>
          <year>1993</year>
          <volume>77</volume>
          <fpage>616</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">8218028</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kivel&#xE4;</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Puusaari</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Damato</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness</article-title>
          <source>Ophthalmology</source>
          <year>2003</year>
          <volume>110</volume>
          <fpage>2235</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">14597535</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kertes</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Peyman</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
          <article-title>Internal resection of posterior uveal melanomas</article-title>
          <source>Br J Ophthalmol</source>
          <year>1998</year>
          <volume>82</volume>
          <fpage>1147</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">9924302</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Damato</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Hiscott</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Noncontiguous tumor recurrence of posterior uveal melanoma after transscleral local resection</article-title>
          <source>Arch Ophthalmol</source>
          <year>2002</year>
          <volume>120</volume>
          <fpage>1659</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="pmid">12470139</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Case 1. The resected melanoma straddles the ora serrata (Ora). The vitreous base (V) is present. There is hemorrhage at the posterior aspect of the tumor</p>
      </caption>
      <alt-text>Figure 1</alt-text>
      <graphic xlink:href="IndianJOphthalmol-55-380-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Case 1. A. The lobular tumor is not transected. There is microscopic extension of the resected tumor to its lateral margins. B. Tumor cells and erythrocytes are present at the lateral margin (inset) (H/E, A. 10x, B. 100x)</p>
      </caption>
      <alt-text>Figure 2</alt-text>
      <graphic xlink:href="IndianJOphthalmol-55-380-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Case 1. The enucleated, aphakic eye contains proliferative vitreoretinopathy (PVR) and detached, gliotic retina (R). There is no grossly apparent residual melanoma</p>
      </caption>
      <alt-text>Figure 3</alt-text>
      <graphic xlink:href="IndianJOphthalmol-55-380-g003"/>
    </fig>
    <fig id="F4" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Case 1. The choroid terminates (arrow) in the area of the resected tumor. Detached, gliotic retina (R) is present in this area (H/E, 25x)</p>
      </caption>
      <alt-text>Figure 4</alt-text>
      <graphic xlink:href="IndianJOphthalmol-55-380-g004"/>
    </fig>
    <fig id="F5" position="float">
      <label>Figure 5</label>
      <caption>
        <p>Case 3. The resected melanoma is multilobed. The posterior aspect of the melanoma is transected (arrow)</p>
      </caption>
      <alt-text>Figure 5</alt-text>
      <graphic xlink:href="IndianJOphthalmol-55-380-g005"/>
    </fig>
    <fig id="F6" position="float">
      <label>Figure 6</label>
      <caption>
        <p>Case 3. A. The resected melanoma is lobular. B. (inset) The area of posteriorly transected tumor (between arrows) is visible on low magnification (H/E, A. 5x, B. 25x)</p>
      </caption>
      <alt-text>Figure 6</alt-text>
      <graphic xlink:href="IndianJOphthalmol-55-380-g006"/>
    </fig>
    <fig id="F7" position="float">
      <label>Figure 7</label>
      <caption>
        <p>Case 3. A nodule of recurrent (residual) melanoma (arrow) is present in the enucleated eye</p>
      </caption>
      <alt-text>Figure 7</alt-text>
      <graphic xlink:href="IndianJOphthalmol-55-380-g007"/>
    </fig>
    <fig id="F8" position="float">
      <label>Figure 8</label>
      <caption>
        <p>Case 3. The transected portion of recurrent (residual) melanoma is hemorrhagic (between arrows) (H/E, 25x)</p>
      </caption>
      <alt-text>Figure 8</alt-text>
      <graphic xlink:href="IndianJOphthalmol-55-380-g008"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
